The evaluation of PD-L1 as a potential biomarker for estimating the inflammation grade in patients with obesity, revealed that the circulating levels of PD-L1 were lower in the obese group, in contrast with the elevated levels of proinflammatory markers. Here, CD274 is linked to obesity disorder.